Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18 ; volume:7 ; number:1 ; day:10 ; month:12 ; year:2009 ; pages:1-9 ; date:12.2009
Journal of translational medicine ; 7, Heft 1 (10.12.2009), 1-9, 12.2009
- Urheber
-
Alagkiozidis, Ioannis
- Beteiligte Personen und Organisationen
-
Facciabene, Andrea
Carpenito, Carmine
Benencia, Fabian
Jonak, Zdenka
Adams, Sarah
Carroll, Richard G.
Gimotty, Phyllis A.
Hammond, Rachel
Danet-Desnoyers, Gwen-äel
June, Carl H.
Powell, Daniel J.
Coukos, George
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-7-104
- URN
-
urn:nbn:de:1111-2016041433641
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alagkiozidis, Ioannis
- Facciabene, Andrea
- Carpenito, Carmine
- Benencia, Fabian
- Jonak, Zdenka
- Adams, Sarah
- Carroll, Richard G.
- Gimotty, Phyllis A.
- Hammond, Rachel
- Danet-Desnoyers, Gwen-äel
- June, Carl H.
- Powell, Daniel J.
- Coukos, George
- SpringerLink (Online service)
Ähnliche Objekte (12)
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Surviving
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Surviving
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts
Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Tierexperimentelle Untersuchung an der Ratte : die Wirkung von Doxorubicin und liposomal verkapseltem Doxorubicin auf Immunsystem und Metastasenbildung
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Surviving
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial